Ipamorelin FAQ: Common Questions, Answered from the Research
What does ipamorelin do for you?
In studies, ipamorelin triggers a pulse of growth hormone (GH) by activating the ghrelin receptor (GHS-R1a) on pituitary cells — and does so without raising cortisol or prolactin, which is its defining trait [1]. People in research-use communities most often report better sleep and faster recovery, but those are anecdotal. No human trial has confirmed a wellness benefit.
Does ipamorelin increase IGF-1?
Not reliably in short studies. A GH pulse can drive the liver to make IGF-1, but a 15-day rat study raised bone growth with no measurable change in total IGF-1 [4]. Sustained, longer protocols of related peptides did raise IGF-1 over 30 days [13]. So whether ipamorelin raises IGF-1 depends heavily on how long and how it is given.
What does ipamorelin peptide do?
The ipamorelin peptide is a synthetic five-amino-acid chain that makes the pituitary release a burst of the body's own growth hormone, by mimicking the hunger hormone ghrelin at the GHS-R1a receptor [1]. Its standout feature is selectivity: it releases GH without the cortisol and prolactin spikes seen with older peptides [1]. It is GH-releasing, not GH itself.
Does ipamorelin build muscle?
No controlled human trial has shown that ipamorelin builds muscle. The evidence is indirect: it reliably releases GH [1], and in mice it shifted body composition — but partly by raising fat and leptin through the ghrelin receptor, even without GH [17]. A 2026 sports-medicine review classed it as investigational with no reproducible human musculoskeletal evidence [14].
What is ipamorelin?
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) and the first selective growth hormone secretagogue — it triggers a GH pulse by activating the ghrelin receptor while sparing cortisol and prolactin [1]. Developed by Novo Nordisk in the 1990s, it was investigated for postoperative ileus but never approved as a drug anywhere [3].
What is ipamorelin peptide?
Ipamorelin peptide is a lab-made chain of five amino acids that acts as a selective ghrelin-receptor (GHS-R1a) agonist, prompting the pituitary to release a pulse of growth hormone without raising stress hormones [1]. It is wholly synthetic — not a hormone the body makes — and is sold only as a research chemical, with no approved medical use [3].
What are the risks of ipamorelin?
The honest answer is that long-term human risk is unknown — no Phase 3 trial was ever run. Known concerns are mechanistic: GH-axis stimulation raises theoretical cancer and blood-sugar questions [1], and a 28-day study of a related ghrelin-receptor agonist found heart-muscle damage in rats [6]. The single 7-day human trial showed no specific safety signal in that short window [3].
Does ipamorelin reduce belly fat?
No human trial has tested ipamorelin for belly fat. In a 2024 ferret study it reduced chemotherapy-driven weight loss by about 24% [5], and in mice it actually raised fat mass through the ghrelin receptor even without GH [17]. Community reports of a leaner look over weeks are anecdotal and confounded by diet and training. The fat-loss claim is not established.
What are the downsides of ipamorelin?
The biggest downside is the evidence gap: its one human efficacy trial failed its primary endpoint [3], and there is no long-term human safety data. Mechanistic concerns include effects on blood sugar and a class-level heart signal from a related peptide [6]. Community-reported downsides — flushing, tingling, water retention, increased hunger — are anecdotal and detailed on the effects page.
Why is ipamorelin being discontinued?
Ipamorelin was never a marketed drug to discontinue — its clinical development stopped because its only Phase 2 trial (for postoperative ileus) missed its primary endpoint, with no efficacy shown over placebo [3]. Separately, in 2024 the FDA tightened compounding-pharmacy access by removing ipamorelin acetate from its interim 503A bulk-substances Category 2, which limited a supply route.
What does CJC-1295 and ipamorelin do?
Together, CJC-1295 (a GHRH analog) and ipamorelin (a ghrelin-receptor agonist) are meant to raise growth hormone through two complementary pathways at once [1]. Class-level data show a GHRP plus GHRH produces more GH output than either alone [13]. But the specific combination has never been tested in a controlled trial for any health outcome, so its real-world effect is unproven.
How does CJC-1295 ipamorelin work?
CJC-1295 ipamorelin works by hitting two different receptors on the same GH-releasing pituitary cell: ipamorelin activates the ghrelin receptor (GHS-R1a) for a GH pulse [1], while CJC-1295 mimics GHRH at the GHRH receptor. Because the pathways are independent, combining them amplifies GH release more than either alone in class-level studies [13]. The combination itself is untested in trials.
How much CJC-1295 ipamorelin should I take?
There is no research-based dose for this combination, and this digest will not provide one. No controlled human trial has studied cjc-1295 ipamorelin together [3]. Community 'stack' regimens have no peer-reviewed dosing basis. The only human ipamorelin doses on record are intravenous research doses given under medical supervision for unrelated purposes [2].
Does CJC-1295 ipamorelin work?
For raising GH output, the mechanism is sound and class-level data support combining a GHRP with a GHRH analog [13]. For producing a health outcome — muscle, fat loss, anti-aging — no controlled trial has tested the combination, so "works" in that sense is unproven [3]. The popularity rests on single-agent pharmacology, not combination results.
How to reconstitute CJC-1295 ipamorelin 5mg?
This site does not provide reconstitution instructions for use in a person. As context only: peptides like ipamorelin ship as a freeze-dried (lyophilized) powder and, in the research-supply literature, are mixed with bacteriostatic water and kept refrigerated, since heat and freeze-thaw cycles degrade them [2]. These are general laboratory-handling notes, not a preparation recipe.
How long does ipamorelin stay in your system?
Not long. In healthy human volunteers, ipamorelin had a terminal half-life of about 2 hours, with clearance of 0.078 L/h/kg [2]. Because each half-life roughly halves the amount remaining, the peptide itself is largely cleared within several hours, even as the GH pulse it triggers peaks around 40 minutes after dosing [2].
Does ipamorelin make you hungry?
It can. Ipamorelin acts on the ghrelin receptor — the same one the body's hunger hormone uses — and ghrelin-receptor peptides activate appetite centers in the brain [18]. Community reports describe increased hunger after injecting, though usually milder than with the older peptide GHRP-6 [1]. Appetite was not a measured endpoint in the human trials.
Will I gain weight on ipamorelin?
It is possible. In mice, ipamorelin raised body weight and fat mass even without GH, through the ghrelin receptor [17], and the appetite effect can increase food intake [18]. But no human trial measured weight change as a wellness outcome, and the 7-day surgical trial was too short to assess it [3]. Any weight change in practice is unverified and confounded by diet.
Does ipamorelin increase appetite?
By mechanism, yes — it activates the ghrelin receptor, and ghrelin-receptor agonists drive feeding and switch on hypothalamic appetite centers in animals [18]. A 2026 sports-medicine review notes the appetite-stimulating, orexigenic nature of GH-axis secretagogues like ipamorelin [14]. Community reports describe this as milder than with GHRP-6, but it is a real class effect.
How long does it take for ipamorelin to work?
On the hormonal level, fast: the GH pulse peaks roughly 40 minutes after a dose in human pharmacology data, and the peptide clears with a ~2-hour half-life [2]. On the subjective level, community reports of sleep changes often describe one to two weeks, but those are anecdotal and unverified — no controlled trial has measured a time-to-benefit for any wellness outcome.
Does ipamorelin cause water retention?
Some users report mild, transient puffiness in the first few weeks, often described as milder than with older GHRP compounds [3]. Mechanistically it is plausible — excess GH is associated with sodium and water retention — but water retention was not a measured endpoint in the human trials, so this rests on anecdote and GH-axis biology, not controlled data.
Where to inject CJC-1295 ipamorelin?
This site does not give injection-site directions for use in a person. In research, ipamorelin has been administered subcutaneously, intravenously, intraperitoneally, and intranasally depending on the study and species [5]. Class-level human research uses subcutaneous infusion for GH-secretagogue protocols [13], but the community self-injection route has no published human safety or technique guidance.